The Federal War on Trans Healthcare: What Happened in 2025 and What Donors Need to Know
From the Supreme Court's Skrmetti ruling to executive orders targeting gender-affirming care, 2025 reshaped transgender healthcare access nationwide. Here's what changed and why donor funding is critical.
The year 2025 was devastating for transgender healthcare in the United States. A Supreme Court ruling, executive orders, state-level bans, and hospital program closures combined to create the most hostile environment for gender-affirming care since these treatments became widely available.
For donors who want to understand why transgender healthcare funding matters now more than ever, here's what happened — and what's at stake.
The Supreme Court upheld trans healthcare bans
In June 2025, the Supreme Court decided United States v. Skrmetti, upholding Tennessee's ban on gender-affirming care for minors. The ruling gave constitutional cover to every state seeking to restrict access to puberty blockers, hormone therapy, and surgical care for transgender youth.
The impact was immediate. States that had been waiting for legal clarity moved forward with their own restrictions. By the end of 2025, twenty-seven states had enacted laws restricting or banning gender-affirming care for minors, affecting an estimated 120,400 transgender young people.
Executive action expanded the attack
Shortly after the Skrmetti decision, President Trump signed Executive Order 14187, directing federal agencies to end support for gender-affirming care for people under 19. The Department of Health and Human Services followed with regulatory actions threatening Medicare and Medicaid funding for hospitals and institutions providing gender-affirming care.
The consequences rippled through the healthcare system. Children's National Medical Center in Washington, DC — right in CE Repro Fund's backyard — shut down its pediatric gender care program. Families who had been receiving care for years were suddenly without providers.
Adults are affected too
The public debate has focused heavily on minors, but adult transgender people are increasingly caught in the crossfire. In Florida and Missouri, restrictions now affect adult HRT access. Published research documents patients being denied prescriptions they've taken for years, and pharmacies refusing to fill them.
The research is clear about the stakes. Studies consistently show that the vast majority of people receiving gender-affirming hormone therapy report improved quality of life, reduced depression and anxiety, and greater life satisfaction. Restricting access to these treatments has measurable, harmful consequences for the people who depend on them.
When access is cut off, some patients turn to unregulated hormone sources — a dangerous alternative to monitored medical care. Others face severe mental health consequences. Donor funding for legitimate, medically supervised HRT is literally life-saving.
Shield laws and telehealth are the lifeline
In response to these restrictions, 18 states plus DC have enacted shield laws protecting providers who deliver gender-affirming care via telehealth to patients in restrictive states. These laws prevent out-of-state investigations, block extradition attempts, and protect provider licenses.
Organizations like HRT@Home, operating out of the DC-Maryland area, use these shield law protections to prescribe HRT to patients across 48 states — including states where in-person access to gender-affirming care has been restricted or eliminated.
CE Repro Fund provides direct financial assistance to patients accessing these services. When a patient in Texas can't afford a telehealth HRT appointment and medication, our funding closes that gap.
Why donor funding is the answer
Government funding for gender-affirming care is being withdrawn at every level — federal, state, and institutional. Insurance coverage is being contested. Hospitals are closing programs. In this environment, private donor funding through nonprofit organizations is the only reliable pathway to care for many transgender people.
CE Repro Fund is one of the few nonprofit organizations that funds transgender HRT alongside abortion care and birth control. We believe these services are connected by a shared commitment to bodily autonomy, and we fund them all through the same direct-assistance model.
What you can do
Donate. Your financial support directly funds HRT for transgender patients who cannot afford care. $50 covers a month of medication. $1,000 covers a full year of treatment including provider visits and lab work.
Learn. Understanding the policy landscape helps you advocate effectively. Share this article with people who may not know what's happening to transgender healthcare access.
Advocate. Contact your elected representatives. Support shield law legislation in your state. Oppose restrictions on gender-affirming care at every level.
The transgender community is under unprecedented attack. Your donation to CE Repro Fund is a concrete act of solidarity — funding the care that politicians are trying to take away.